After years of operating as Verisk Health, the data-driven healthcare company is giving itself a makeover with a rebranding initiative.
Beginning today, the company will now operate under the name Verscend Technologies, the company said in a statement.
The name change comes only two weeks after Emad Rizk, MD, took over the company as CEO. Rizk, who has worked at the executive level in healthcare for more than 25 years, was previously CEO at Accretive Health, a Chicago-based revenue cycle management company.
Verscend, based in Waltham, Massachusetts, helps develop more positive outcomes for providers by giving them information, opportunities and recommendations about payment accuracy, revenue integrity, population risk analytics and quality improvement.
“The name Verscend is an important milestone on our path to be an independent organization and a tribute to our future as a stand-alone entity,” Rizk said. “The name Verscend implies growth, ascension, momentum and symbolizes the company’s commitment to optimize healthcare and create better outcomes.”
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.